1Adnan AZ,David HV.Multiple myeloma:an old disease with new hope for the future.CA Cancer J Clin,2001,51:273-285.
2Santos ES,Goodman M,Bymes JJ,et al.Thalidomide effects in the post-transplantation setting in patients with multiple myeloma.Hematology,2004,9:35-39.
3Stewart AK,Chen CI,Howson-Jan K,et al.Results of a multicenter randomized phase Ⅱ trial of thalidomide and prednisone maintenance therapy for multiple myeloma afer autologous stem cell transplant.Clin Cancer Res,2004,10:8170-8176.
4BladéJ,Samson D,Reece D,et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation.Myeloma Subcommittee of the EBMT.European Group for Blood and Marrow Transplant.Br J Haematol,1998,102:1115-1123.
5Attal M,Harousseau JL,Leyvras S,et al.Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.Blood,2006,102:3289-3294.
